Leslie Tive

Dr. Leslie Tive

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Postgraduate Medicine
Verified
Journal Article
Open access
SNSri Nalamachu
Sri Nalamachu
RRRebecca L Robinson
Rebecca L Robinson
LVLars Viktrup
Lars Viktrup
JCJoseph C Cappelleri
Joseph C Cappelleri
ABAndrew G. Bushmakin
Andrew G. Bushmakin
JJJames Jackson
James Jackson
To evaluate healthcare resource utilization (HCRU) by osteoarthritis (OA) pain severity.Cross-sectional surveys of US physicians and their patients were conducted between February and May 2017. Usi...

11 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TSThomas J. Schnitzer
Thomas J. Schnitzer
RRRebecca L Robinson
Rebecca L Robinson
LVLars Viktrup
Lars Viktrup
JCJoseph C Cappelleri
Joseph C Cappelleri
ABAndrew G. Bushmakin
Andrew G. Bushmakin
JJJames Jackson
James Jackson
Opioids are often prescribed for osteoarthritis (OA) pain, despite recommendations to limit use due to minimal benefits and associated harms. This study aimed to assess physicians’ practice patterns and perceptions regarding opioids by specialty one year following the Centers for Disease Control and Prevention (CDC) published guidance on opioid prescribing. The 139/153 (90.8%) physicians who reported prescribing opioids in the previous year reported decreased prescribing for mild OA (51.3%, 26.5% and 33.3% of primary care physicians, rheumatologists, and orthopaedic surgeons, respectively), moderate OA (50.0%, 47.1% and 48.1%) and severe OA (43.6%, 41.2% and 44.4%). Prescribing changes were attributed to the CDC guidelines for 58.9% of primary care physicians, 59.1% of rheumatologists, and 73.3% of orthopaedic surgeons. Strong opioids were mostly reserved as third-line treatment. Although treatment effectiveness post-CDC guidelines was not assessed, perceptions of efficacy and quality of life with opioids significantly differed across specialties, whereas perceptions of safety, convenience/acceptability and costs did not. Physicians generally agreed on the barriers to opioid prescribing, with fear of addiction and drug abuse being the most important. Across specialties, physicians reported decreased opioid prescribing for OA, irrespective of OA severity, and in most cases attributed changes in prescribing to the CDC guideline.

Verified
Journal Article
Open access
PDF file
TSThomas J. Schnitzer
Thomas J. Schnitzer
RRRebecca L Robinson
Rebecca L Robinson
LVLars Viktrup
Lars Viktrup
JCJoseph C Cappelleri
Joseph C Cappelleri
ABAndrew G. Bushmakin
Andrew G. Bushmakin
JJJames Jackson
James Jackson
Patients often take opioids to relieve osteoarthritis (OA) pain despite limited benefits and potential harms. This study aimed to compare cross-sectional perspectives of patients that were taking prescription opioid (N = 471) or nonopioid medications (N = 185) for OA in terms of satisfaction, expectations of effectiveness, and concerns. Patients prescribed opioids (>7 days) reported more prior treatments (2.47 vs. 1.74), greater mean pain intensity (5.47 vs. 4.11), and worse quality of life (EQ-5D-5L index value mean 0.45 vs. 0.71) than patients prescribed nonopioid medications (all p < 0.0001). Based on linear regression models adjusting for demographics and pain intensity, patients prescribed opioids were less satisfied with overall regimen (3.40 vs. 3.67, p = 0.0322), had less belief that medications were meeting effectiveness expectations (2.72 vs. 3.13, p < 0.0001), and had more concerns about treatments being “not very good” (3.66 vs. 3.22, p = 0.0026) and addiction (3.30 vs. 2.65, p < 0.0001) than patients prescribed nonopioid regimens. When the models were replicated for subgroups with ≥30 days’ medication regimen duration, the findings were consistent with the main analyses. Patients have concerns about the risk of opioid addiction, but those with greater disease burden and more prior treatments continue taking opioid regimens.

5 July 2021 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
LGLouis Garrison
Louis Garrison
PSPatricia Schepman
Patricia Schepman
ABAndrew G. Bushmakin
Andrew G. Bushmakin
RRRebecca L Robinson
Rebecca L Robinson
Leslie TiveLeslie Tive
Leslie Tive
SSStuart Silverman
Stuart Silverman
Purpose: To evaluate the relationship between self-reported concerns about becoming addicted to a medication and health-related quality of life (HRQoL) in patients with osteoarthritis (OA). Methods: This real-world study used patient-level cross-sectional survey data collected from the US Adelphi Disease Specific Programme (DSP). The DSP for OA selected 153 physicians who collected de-identified data on their next nine adult patients with OA. Each patient completed a disease-relevant survey, which included the Likert-scale question, “I am concerned about becoming addicted to my medicine,” (CAA) with responses ranging from “completely disagree” [1] to “completely agree” [5]. HRQoL was measured by the EQ-5D-5L index value and the EQ Visual Analogue Scale (VAS). A set of ordinary least squares regressions using HRQoL measures as outcomes and CAA as a continuous predictor were estimated. Standardized effect size (ES) was used to gauge the magnitude of effects. Results: A total of 866 patients with OA completed the survey (female, 61.2%; White, 77.7%; mean age, 64.2 years). Of the 775 patients who completed the CAA question, almost one-third responded that they “agree” (18%) or “completely agree” (11%), while 27% responded “completely disagree” and 20% “disagree.” Regression analyses found that patients who have concerns about medication addiction have significantly different EQ-5D-5L index values and EQ VAS scores compared with patients who do not have this concern (p < 0.0001). Conclusion: Our findings suggest that concern about medication addiction in patients with OA may have an impact on patient HRQoL, with more concerned patients reporting poorer HRQoL outcomes.

1 April 2015 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
Leslie TiveLeslie Tive
Leslie Tive
DRD. Radin
D. Radin
ABA. Bello
A. Bello
MBM. Brown
M. Brown
CWC. West
C. West
KVK. Verburg
K. Verburg

1 April 2018 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
TST.J. Schnitzer
T.J. Schnitzer
ABA.E. Bello
A.E. Bello
CWC.R. West
C.R. West
GPG.C. Pixton
G.C. Pixton
Leslie TiveLeslie Tive
Leslie Tive